Luis Felipe Burigotto Rocco
BRAZIL
Meet Luis Felipe Burigotto Rocco - a powerhouse of good design, creativity and innovation based in Brazil. Luis Felipe Burigotto Rocco's design journey has been nothing short of spectacular, marked by a tireless pursuit of excellence. This dedication is clearly mirrored in Luis Felipe Burigotto Rocco's impressive haul of 2 A' Design Awards that we showcase here. Spanning across categories such as Yacht and Social, Luis Felipe Burigotto Rocco's work stands as a living testament to a steadfast commitment to design excellence, serving as a beacon of inspiration for designers globally. With each project, Luis Felipe Burigotto Rocco masterfully blends form and function, crafting designs that are not only aesthetically pleasing but also functional and timeless. This approach underscores Luis Felipe Burigotto Rocco's celebration of creativity and an unyielding quest for innovation.
View Profile Consult Now Hire NowAll started with the idea of developing a great new yacht concept, with the priority of creating a large play area in the stern with a large swimming pool and lounge area with wide view of the sea and with the challenge of having a great clearance between floors. The design would then have to be completely different from the already designed today. I drew a profile so that the upper deck was interrupted course, thus forming the double foot straight aft. Large side windows and large column form the profile of a harmonic way and aggressive.
|
|
It all started with the tragic moment that the world has experienced in recent times and challenged the designer Luis Felipe Rocco to create a hospital ship with the maximum renewable energy capacity to operate in the most difficult area. Considering that a billion people live in coastal regions, a hospital ship with this capability is a fast and economical way to reach to this area.The Blue Frontiers Ship works with 12 decks, large area of relaxation and conviviality on the top floor and capacity for 500 people working for the benefit of 160 patients.
|
|
|